Newsletter

You can unsubscribe from this list at any time by Clicking Here and HITTING SEND. You can also unsubscribe by going to http://listserv.otcjournal.com and entering your email address there while selecting unsubscribe.


OTC Journal Newsletter
June 24, 1999	Volume II, Issue 27

Email : info@otcjournal.com
URL : http://www.otcjournal.com

To OTC Journal Members:

On Tuesday went sent out an update on US Microbics (OTC BB: BUGS) because we felt that the stock had drifted down to a ridiculously low level, and was worth reviewing at those levels.

Since when the stock was $3.25, it has rebounded nicely and closed today at $3.44 bid, $3.75 ask, yielding a 6% move since yesterday.

Most micro cap stocks will tend to trade within a certain range until fundamental developments at the Company and recognition from investors drives the stock either well above or well below the range it had been trading in. In the case of US Microbics, the range seems to be $3 on the low end and $5 on the high. Currently, the range on our parent company, 1st Net Technologies (OTC BB:FNTT) seems to be $5.50 on the low end, and $8 on the high end.

We always try to bring you the most current information we can get on these companies at a time that provides a favorable entry point to our members, as was the case with US Microbics. Stocks like these tend to provide excellent returns if the Company executes its business plan and investors are prepared to hold for the long term. However, it is always psychologically easier to hold a stock if you own it at the bottom of its trading range.

Today, US Microbics issued a press release concerning the efficacy of one of its processing products, which we have provided for your convenience. Here is the press release:

June 24, 1999 12:51

Bio-Raptor Converts Horse Manure into Soil Amendment

CARLSBAD, Calif., June 24 /PRNewswire/ -- U.S. Microbics, Inc., (OTC Bulletin Board: BUGS) announced today that the company's patented Bio-Raptor(TM) process and proprietary microbial mixtures have successfully reduced offensive odors, pathogens, and seeds from horse manure and turned the organic matter into a high quality soil amendment for landscape and architectural projects.

The Bio-Raptor(TM), a shredder, conveyor, and screening system, is ideally suited for solid manure applications including horse, dairy, and chicken sites. The one-step Bio-Raptor(TM) process pulverizes, aerates, and sprays the manure with a microbial blend. Recent tests with horse manure have shown impressive results including: odor reduction within 3 days, pathogen and seed reduction within seven days, volume reduction up to forty five percent, and ammonium reduction of 95%. Typical untreated composted manures may take up to one year to naturally decompose and may not control their orders. With a nominal speed of 100-300 tons per hour, the Bio-Raptor(TM) can process large quantities of material in short periods of time.

This decreased processing time obtained with the Bio-Raptor(TM) and microbes means the manure owner can convert additional manure into soil amendments in the same amount of time, significantly increase the production in the same amount of physical space, or substantially decrease the amount of acreage to process a given amount of manure. All three benefits can decrease costs or increase revenue to the manure processor. With the addition of green waste, sand, black soil or additional processed manure types, a rich soil amendment can be created and is often in demand by landscape contractors for new housing developments. Supplementing the soil amendment with additional microbes may often enhance plant growth, appearance, and yield, and reduce water consumption, pumping charges and fertilizer requirements.

Robert Brehm, CEO of U.S. Microbics, states, "Now that we have proven the effectiveness of the treatment process, we plan to continue our own manure processing operations and offer the product and process to other manure handlers including racetrack operators, farmers, ranchers and topsoil producers, who want quicker, cheaper non-chemical alternatives to manure disposal or conversion into sellable products."

For further information about U.S, Microbics, Inc., contact investor relations at 760-918-1860 or visit the website at http://bugsatwork.com.

The information contained in this press release includes forward-looking statements. Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "expect," or similar expressions that involve risks and uncertainties. These risks and uncertainties include the Company's status as a startup company with uncertain profitability, need for significant capital, uncertainty concerning market acceptance of its products, competition, limited service and manufacturing facilities, dependence on technological developments and protection of its intellectual property. The Company's actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences are discussed more fully in the "Risk Factors," "Management's Discussion and Analysis or Plan of Operation" and other sections of the Company's Form 10-KSB and other publicly available information regarding the Company on file with the Securities and Exchange Commission. The Company will provide you with copies of this information upon request.

SOURCE U.S. Microbics, Inc.

/CONTACT: Robert Brehm, CEO of U.S. Microbics, Inc., 760-918-1860/

/Web site: http://bugsatwork.com/

Links to Free Downloads

Disclaimer

The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. All statements and expressions are the sole opinions of the editors and are subject to change without notice. This profile is neither an offer nor solicitation to buy or sell any securities mentioned. This newsletter is owned by SSP Management, Inc, a wholly owned subsidiary of 1st Net Technologies, Inc ("1st Net"). While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. The editor, members of the editor's family, and/or entities with which they are affiliated, may own stock in and have other financial dealings with the companies who appear in the publication. To that degree, this newsletter should not be regarded to be an independent publication. SSP Management has received the following compensation for representing US Microbics for a period of one year: $50,000 in cash, and 50,000 options convertible into restricted stock, exercisable at $1 per share. In a related transaction, SSP Management intends to exercise its option by signing a promissory note to US Microbics for $50,000. The OTCjournal.com critiques may contain forward looking statements relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.